Biography
Biography: William G Whitford
Abstract
The digital biomanufacturing (DB) revolution is changing the way biopharmaceuticals are being produced. Keys to this initiative include increased monitoring, data collection, connectivity, computing power, control algorithms and automation.DB is part of an evolution: One further step in the application of the IIoT and cloud computing. Enterprise systems connect disparate data from new sensors and on-line analytics, along with such other high value information as process history records, into advanced process control algorithms. More than instruments becoming interconnected, DB denotes high levels of data analysis,information management and process control in a “process network”. By this, manufacturers’ gain actionable intelligence, transformative insights, and more effective process control. Supported by DB, EMS designs are moving beyond highly automated, to becoming a nearly autonomous source of integrated resource, supply chain and customer relationship management.
Recent Publications
1.Whitford W G, Hoying J B (2017) Digital biomanufacturing supporting vascularization in 3D bioprinting. International Journal of Bioprinting 3(1): 1-9.
2.Whitford W G, James Hoying (2016) A bioink by any other name: Terms, concepts and constructions related to 3D bioprinting. Future Science OA 2: 3.
Speaker Presentations
Speaker PPTs Click Here